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ABSTRACT 
Spontaneous purinergic neurotransmission was characterised in the mouse urinary 
bladder, a model for the pathological or ageing human bladder. Intracellular 
electrophysiological recording from smooth muscle cells of the detrusor muscle 
revealed spontaneous depolarizations, distinguishable from spontaneous action 
potentials (sAPs) by their amplitude (<40 mV) and insensitivity to the L-type Ca2+ 
channel blocker nifedipine (1 μM) (100 ± 29%). Spontaneous depolarizations were 
abolished by the P2X1 receptor antagonist NF449 (10 μM) (frequency 8.5 ± 8.5% of 
controls), insensitive to the muscarinic acetylcholine receptor antagonist atropine (1 
μM) (103.4 ± 3.0%), and became more frequent in latrotoxin (1 nM) (438 ± 95%), 
suggesting that they are spontaneous excitatory junction potentials (sEJPs). Such 
sEJPs were correlated, in amplitude and timing, with focal Ca2+ transients in smooth 
muscle cells (measured using confocal microscopy), suggesting a common origin: ATP 
binding to P2X1 receptors. sAPs were abolished by NF449, insensitive to atropine (126 
± 39%) and increased in frequency by LTX (930 ± 450%) suggesting a neurogenic, 
purinergic origin, in common with sEJPs. By comparing the kinetics of sAPs and 
sEJPs, we demonstrated that sAPs occur when sufficient cation influx through P2X1 
receptors triggers L-type Ca2+ channels; the first peak of the differentiated rising phase 
of depolarizations - attributed to the influx of cations through the P2X1 receptor - is of 
larger amplitude for sAPs (2248 mV.s-1) than sEJPs (439 mV.s-1). Surprisingly, sAPs in 
the mouse urinary bladder, unlike those from other species, are triggered by stochastic 
ATP release from parasympathetic nerve terminals rather than being myogenic. 
 
Keywords: Detrusor, parasympathetic, smooth muscle.
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INTRODUCTION 
In most mammals, excitation of the detrusor muscle of the urinary bladder is achieved 
through the parasympathetic activation of both purinergic and cholinergic 
neurotransmission, leading to voiding of the bladder. The brief, initial phase of 
contraction is atropine-insensitive (Henderson & Roepke, 1934) and purinergic 
(Burnstock et al. 1978); the second phase, of longer duration, is cholinergic (Krell et al. 
1981). The balance between purinergic and cholinergic neurotransmission observed 
experimentally varies widely. This variation is often attributed to three factors: (i) 
Species used. Detrusor contraction is almost entirely controlled by purinergic 
neurotransmission in cat (Nergårdh, 1981) and rabbit (Sibley, 1984), whereas 
cholinergic neurotransmission dominates in the Old World primates (Craggs & 
Stephenson, 1985). (ii) Age. For example, there is an increase with age in the 
contribution of purinergic neurotransmission to bladder voiding in the human (Yoshida 
et al. 2001) and rat (Saito et al. 1991). (iii) Experimental protocol. Single pulse or low 
frequency, repetitive transmural electrical stimulation evokes an atropine-insensitive 
contraction (Ambache & Zar, 1970); high frequency repetitive stimulation evokes 
excitation that comprises a much larger proportion of cholinergic than purinergic 
neurotransmission (Sibley, 1984). 
Normal voiding of the human bladder is attributed to the actions of acetylcholine 
as the primary excitatory neurotransmitter. The administration of the muscarinic 
cholinergic receptor antagonist atropine to healthy subjects resulted in difficulty in 
initiating, and pain during, micturition (Cullumbine et al. 1955) and in some in vitro 
studies, atropine was shown to abolish electrically-evoked contraction (Sjörgen et al. 
1982; Sibley, 1984). There are other in vitro studies, however, which suggest a role for 
purinergic neurotransmission in normal voiding; Cowan and Daniel (1983), for example, 
demonstrated that atropine abolished only 50% of stimulated contractions, and others 
(e.g. Elmér et al. 1986; Hoyle et al. 1989; Luheshi & Zar, 1990) have shown atropine-
resistant contractions, albeit comprising a smaller proportion of excitatory 
neurotransmission than is attributed to the actions of acetylcholine. The wide variation 
in reported contributions of purinergic neurotransmission to bladder voiding is partly 
explained by the methodological difficulty of evoking neural stimulation without also 
evoking potentially-masking direct muscle stimulation (Hoyle et al. 1989). It is, 
however, generally agreed that purinergic neurotransmission is up-regulated in bladder 
dysfunction; Sjörgen et al. (1982) demonstrated, for example, that while atropine 
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abolished contractions in preparations from normal bladders, preparations from 
pathological bladders exhibited contractions that were up to 50% atropine resistant. 
It has been demonstrated that ATP, released from parasympathetic nerve 
terminals, binds to P2X receptors (Burnstock & Kennedy, 1985, Howson et al. 1988) on 
urinary bladder smooth muscle cells (SMCs), producing an excitatory junction potential 
(EJP) that triggers the opening of L-type Ca2+ channels and the subsequent initiation of 
an action potential (Hoyle & Burnstock, 1985; Howson et al. 1988). Heppner et al. 
(2005) recently identified purinergic focal Ca2+ transients, corresponding to the influx of 
Ca2+ through P2X receptors upon ATP binding in rat urinary bladder smooth muscle. 
In summary, although purines may not be the major excitatory 
neurotransmitters responsible for human bladder voiding, their up-regulated role in 
pathological states and with ageing makes purinergic neurotransmission a key area of 
study. The aims of the present study are to: (i) use simultaneous electrophysiological 
recording of membrane potential and high-speed imaging of Ca2+ fluorescence to 
determine whether a relationship exists between spontaneous purinergic Ca2+ 
transients and spontaneous depolarizations in mouse urinary bladder smooth muscle, 
and (ii) to characterise spontaneous depolarizations and, in particular, to determine the 
mechanisms underlying their generation.
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METHODS 
 
General 
Mice of C57BL/6 strain, of either sex, weighing 18 – 30 g, were killed by head 
concussion followed by cervical dislocation. Efforts were made to minimise the number 
of animals used and their suffering; all experiments were carried out in accordance with 
the UK Animals (Scientific Procedures) Act 1986 and European Communities Council 
Directive 86/09/EEC. 
The urinary bladder was removed and its ventral wall was opened longitudinally 
from the bladder neck (posterior) to the top of the dome (anterior). The urothelium was 
removed by careful dissection using iris scissors; care was taken not to stretch or 
damage the underlying detrusor muscle. Tissue strips, which contained a few bundles 
of smooth muscle, 6 – 8 mm long and 1 – 2 mm wide, were cut along the craniocaudal 
axis of the dorsal surface of the detrusor. Strips were pinned out on a Sylgard (Dow 
Corning Corporation, Midland, MI, U.S.A.) -lined plate at the bottom of a shallow 
chamber (volume, approximately 1 ml), which was mounted on the stage of an upright 
microscope. Preparations were superfused with warmed (35 ˚C) physiological saline 
solution (PSS) (composition, mM: NaCl, 120; KCl, 5.9; MgCl2, 1.2; CaCl2 2.5; NaHCO3, 
15.5; NaH2PO4, 1.2 and glucose, 11.5; gassed with 95% O2 and 5% CO2) at a constant 
flow rate (100 ml.h-1), maintaining a pH of 7.2 – 7.3 (Hashitani & Brading, 2003). 
Preparations, when pinned, were allowed to equilibrate (i.e. to accommodate under 
tension) for at least 30 mins before electrophysiological recording or Ca2+ imaging. 
 
Electrophysiological recordings 
Individual bladder smooth muscle cells in muscle bundles were impaled with glass 
capillary microelectrodes, filled with 0.5 M KCl (tip resistance, 100 – 300 MΩ). 
Membrane potential changes were recorded using a high input impedance amplifier 
(Axoclamp-2B, Axon Instruments, Inc., Sunnyvale, CA, U.S.A.), and displayed on a 
digital oscilloscope (DSO 1602, Gould, Ilford, Essex, UK). Membrane potential changes 
were digitized using PowerLab/4SP (ADInstruments, Chalgrove, Oxfordshire, UK) at 4 
kHz and stored on computer for later analysis. 
Recordings were made from a minimum of six cells, for at least 5 minutes each, 
in the absence of drugs (‘control’ measurements). One long, continuous recording was 
then made, which included a control period (typically 10 mins), and then a period (up to 
1 h) in the presence of the drug. Recordings were subsequently made from a further 
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six cells (minimum), for at least 5 minutes each. Subsequent analysis of the effect of 
the superfused reagents compared the median frequency for all cells recorded in 
control period vs. the median frequency of events in the presence of the reagent, in a 
paired comparison. 
 
Ca2+ imaging and analysis 
Each detrusor strip was exposed to 10 μM Oregon Green 488 BAPTA-1 AM 
(Invitrogen, Paisley, Renfrewshire, UK) in 1% DMSO/0.2% pluronic F-127 (Sigma-
Aldrich, St. Louis, MO, USA) in physiological salt solution (PSS) for 70 min at 36 °C. 
The tissue was rinsed in PSS, bubbled with 95% O2/5% CO2, for at least 10 minutes. 
Tissues were pinned flat, serosal side up, in a Sylgard-lined organ bath, and mounted 
on the stage of an upright confocal microscope (Leica SP2 upright confocal 
microscope; Leica Microsystems, Milton Keynes, Buckinghamshire, UK). 
A series of 200 frames was captured at 13.5 Hz to generate one image set. 
Such sets were acquired once every minute. Ten sets were generated for each region 
of the preparation, with at least three regions sampled per drug treatment and / or 
preparation. 
Microelectrodes used for simultaneous confocal recordings (tip resistances of 
200 – 300 MΩ) were filled with a potassium salt of Oregon Green BAPTA-1 (100 μM in 
0.5 M potassium acetate; weight 10 kDa; Invitrogen, UK). The microelectrode tip (or 
part of it) was always within the field of view of the confocal image. 
Image analysis was performed using plug-ins for Image J 
(http://rsb.info.nih.gov/ij/download.html) that were custom-written by Dr R. J. Amos to 
detect focal increases in fluorescence of the Ca2+ indicator. Data were exported to 
Excel (Microsoft, Redmond, WA, USA) for formatting and then to Spike 2 (Cambridge 
Electronic Design, Cambridge, Cambridgeshire, UK) for analysis in conjunction with 
electrophysiological recordings. 
 
Analysis of correlations between focal Ca2+ transients and spontaneous 
depolarizations 
The peak amplitudes of focal Ca2+ transients and spontaneous depolarizations were 
calculated using a custom-written script for Spike 2. The threshold for determining focal 
Ca2+ transients varied between recordings in different SMCs. The threshold was 
adjusted until it provided specificity comparable to manual counting (ΔF/F range of 0.06 
- 0.1). 
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 Occasionally, >1 coincident focal Ca2+ transient was observed within the 
impaled cell. In this instance, the amplitudes of spontaneous depolarizations and focal 
Ca2+ transients were not included in the subsequent analysis. 
 In order to estimate the time of initiation of focal Ca2+ transients, experiments 
were performed in which Ca2+ fluorescence was measured along the long axis of a 
SMC at a high acquisition rate (2 kHz) and the amplitudes and timing of focal Ca2+ 
transients were correlated with the membrane potential of the imaged cell, 
simultaneously measured using the previously-described electrophysiological recording 
technique. Ca2+ fluorescence was measured in a 20 μm-wide window around each 
focal Ca2+ transient for the duration of each acquisition period (approx. 2 s) using 
Image J. Using a custom-written script for R (http://www.r-project.org) a curve was then 
fitted, comprising: 
y = C , before the initiation of the focal Ca2+ transient (i.e. t < to), and 
y = C + A e−k1 . t− to[ ] − e−k2 . t−to[ ]( ), thereafter (i.e. t ≥ to). 
The time of initiation (to) was that giving the minimum residual sum of squares for this 
curve fit. This function arises from a simple model of Ca2+ influx through P2X1 
receptors, with Ca2+ then cleared by a first-order process (see the Appendix). 
 
Drug sources, preparation and application 
Tetrodotoxin (Tocris, Bristol, UK), nifedipine (Bayer, Leverkusen, North Rhine-
Westphalia, Germany) and atropine sulphate (VWR; Lutterworth, Leicestershire, UK) 
were stored frozen (-20 ºC) at a concentration of 10 mM in DMSO. NF449 (at 1 mM; 
Tocris, Bristol, UK) and α-latrotoxin (at 300 nM; Sigma-Aldrich, St. Louis, MO, USA) 
were stored frozen in distilled water. Drugs were diluted to their final concentration in 
PSS and applied to the preparation by switching the superfusate from standard PSS. 
 
Statistical analysis 
The normality and homogeneity of variance was tested prior to further statistical 
analysis using Kolmogorov-Smirnov and Levene’s tests, respectively (SPSS version 
11, SPSS Inc., Chicago, IL, USA). Unless otherwise stated, statistical comparisons are 
Student’s two-tailed paired t-test. The term n, used in the presentation of statistical 
analyses throughout, refers to the number of animals used.
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RESULTS 
Pharmacology of spontaneous depolarizations 
Intracellular recording of smooth muscle cells in the mouse urinary bladder revealed 
both spontaneous depolarization (sDeps) and spontaneous action potentials (sAPs), as 
previously described. sAPs can be distinguished from sDeps by their greater 
amplitude, the presence of an after-hyperpolarization or after-depolarization and their 
sensitivity to the voltage-dependent Ca2+ channel antagonist nifedipine (Meng et al. 
2008). 
In order to determine the mechanisms underlying the generation of sDeps, the 
contributions of purinergic and cholinergic neurotransmission were explored through 
the application of specific antagonists. The purinergic P2X1 antagonist NF449 (10 μM) 
greatly reduced the frequency of sDeps. The frequency at which sDeps were detected 
was reduced from 8.0 ± 3.6 min-1 in control cells to 0.7 ± 0.3 min-1 following 1 h of 
superfusion with NF449 (post-NF449, 8.5 ± 8.5% of controls; P < 0.01, n = 4; Fig. 1Ai, 
1B), with the amplitude of the remaining events reduced to 75 ± 6% of controls (P < 
0.05, n = 4). Superfusion of the P2X1 desensitizing agonist α,β-methylene ATP (α,β-
mATP; 1 μM) reduced the frequency with which sDeps were detected from 11.3 ± 2.0 
min-1 in control cells to 1.4 ± 0.6 min-1 (post α,β-mATP, 11.4 ± 0.6%; P < 0.01, n = 4; 
Fig. 1Aii, 1B) with the amplitude of remaining sDeps reduced to 55 ± 10.% of controls 
(P < 0.05, n = 4). In contrast to NF449 and α,β-mATP, the muscarinic acetylcholine 
receptor antagonist atropine (1 μM) did not affect the frequency of sDeps, which was 
74 ± 31 min-1 in control cells and 76 ± 31 min-1 following 1 h application (post-atropine, 
103.4 ± 2.6% of controls; P = NS, n = 4; Fig. 1Aiii, 1B). 
In the urinary bladder of the guinea pig, it has been reported that some large-
amplitude sEJPs result from spontaneous nerve terminal action potentials (Bramich & 
Brading, 1996). In the present work in mouse urinary bladder, however, TTX (1 μM) did 
not abolish large-amplitude (>10 mV) sDeps (mean range, control: 1.7 – 35.0 mV; TTX, 
following superfusion for 1 h: 1.4 – 31.2 mV, n = 4). TTX (1 μM) also did not affect the 
frequency of sDeps, which was 4.3 ± 0.5 min-1 in control cells, and 7.1 ± 1.1 min-1 
following TTX (post-TTX, 166 ± 55% of controls; P = NS; Fig. 1Aiv, 1B). 
In order to determine whether blocking L-type Ca2+ channels affected the 
frequency at which sDeps were detected, the effect of nifedipine was assessed. 
Nifedipine (1 μM) did not affect the frequency of sDeps, which was 6.6 ± 2.3 min-1 in 
control cells, and 6.5 ± 2.0 min-1 following nifedipine superfusion for 1 h (post-
nifedipine, 100 ± 29% of controls; P = NS; Fig. 1Av, 1B). 
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In order to determine whether the ATP that initiates sDeps comes from nerves, 
experiments were performed in the presence of an extract of the black widow spider 
venom, α-latrotoxin (LTX), which increases the rate of spontaneous neurotransmitter 
release from nerve terminals. Superfusion of LTX (1 nM) for 10 min produced a 438 ± 
95% increase in sDep frequency (to 35.3 ± 8.3 min-1) with respect to the control period 
(9.3 ± 2.6 min-1) (P < 0.05, n = 4; Fig. 2A). The superfusion of atropine (1 μM), in 
addition to LTX (1 nM), produced a similarly large augmentation of sDeps, to 460 ± 
320% (63 ± 13 min-1) of control frequency (13.8 ± 2.8 min-1) (P < 0.05, n = 4; Fig. 2B). 
By contrast, when LTX (1 nM) was superfused in addition to NF449 (10 μM) sDeps 
were completely abolished within 15 mins (n = 4; Fig. 2C). 
 
Pharmacology of spontaneous action potentials 
Spontaneous action potentials (sAPs; of amplitude: 53.4 ± 2 mV) were observed in 
38% of SMCs (i.e. 11 of 29, from n = 4) where they typically occurred at a low 
frequency (0.77 ± 0.20 min-1, range: 0.2 – 2.6). Following superfusion of the P2X1 
antagonist NF449 (10 μM) for 1 h, sAPs were not observed in any SMC (i.e. 28 of 28, 
from n = 4). To confirm that NF449 had no direct effect on L-type Ca2+ channels, SMC 
membrane properties were examined with a series of brief current injections. In control 
cells and those superfused with NF449 (10 μM) for 1 h, current injections ≥ +0.09 nA 
stimulated active currents consistent with normal opening of L-type Ca2+ channels 
(Supplementary Figure 1). 
Superfusion of the P2X1 desensitizing agent α,β-mATP (1 μM) reduced the 
number of SMCs in which sAPs were observed from 17 of 25 (from n = 4) in control 
cells to 4 of 20 following α,β-mATP superfusion (Fisher's Exact test P < 0.05). The 
frequency of sAPs occurring in cells that had at least one sAP was reduced from 1.17 ± 
0.44 min-1 in control cells to 0.141 ± 0.009min-1 (P < 0.05, n = 4). 
By contrast to the effects of NF449 and α,β-mATP, the muscarinic acetylcholine 
receptor antagonist atropine (1 μM) did not affect the frequency of sAPs, which was 
0.54 ± 0.37 min-1 in control cells and 0.89 ± 0.58 min-1 following 1 h application (post-
atropine, 126 ± 39% of controls; P = NS, n = 4). 
In order to determine the contribution of spontaneous activation of nerve 
branches or spontaneous nerve terminal action potentials to sAPs, the frequency of 
sAPs was compared following superfusion of TTX (1 μM). The frequency of sAPs was 
similar in control cells (0.52 ± 0.3 min-1, range: 0.1 – 2.1; observed in 6 of 28 SMCs, 
from n = 4) to those superfused with TTX for 1 h (0.73 ± 0.40 min-1, range: 0.1 – 2.1; 
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observed in 7 of 28 SMCs, from n = 4) (P = NS, Student’s t-test). The amplitudes of 
sAPs were unaffected by TTX superfusion (control: 50.1 ± 3.0 mV, post-TTX: 51.5 ± 
2.0 mV; P = NS, Student’s t-test). 
In order to investigate whether sAPs result from nerve-released ATP, 
experiments were performed in the presence of LTX. Following the superfusion of LTX 
(1 nM) for 10 min, sAP frequency was increased to 930 ± 450% of control (i.e. 1.9 ± 0.5 
min-1 to 11.0 ± 3.1 min-1; P < 0.05, n = 4). sAPs were also increased in frequency 
following superfusion of LTX and atropine (1 μM) (600 ± 370% of control; from 0.4 ± 
0.1 min-1 to 2.8 ± 1.8 min-1; P = NS, n = 3), but sAPs were abolished by LTX and NF449 
(10 μM) (9 ± 5% of control; from 1.5 ± 0.6 min-1 to 0.1 min-1; P < 0.001, n = 4). 
 
The relationship between sDeps and sAPs 
To determine whether sDeps might intermittently initiate sAPs, their kinetics were 
compared. Both sDeps and sAPs occurred with variable rising phases, with times-to-
peak ranging from 5 – 89 ms for sDeps (median: 30 ms, no. of events = 4755; e.g. Fig. 
3A) and 11 – 49 ms for sAPs (median: 19 ms, no. of events = 369; e.g. Fig. 3B). In 
order to test the hypothesis that the more prolonged rise times of sDeps indicate a 
lower peak current after ATP binding to P2X1 receptors, the rising phases of both 
sDeps and sAPs were differentiated and compared. The differentiated rising phases of 
sDeps usually contained one peak, which varied in amplitude with a positively-skewed 
distribution from 0.4 – 4.5 V.s-1 (Fig. 3A). By contrast, the differentiated rising phase of 
sAPs always contained two determinable peaks and the broad amplitude frequency 
distribution (0.6 – 6.3 V.s-1) of the first peak is consistent with the highly variable time-
to-peak of sAPs (Fig. 3B). Comparing the first peak of the differentiated rising phase of 
the depolarization revealed that the amplitude of the first derivative was much greater 
for sAPs (median: 2248 mV.s-1, range: 454 – 4913) than sDeps (median: 439 mV.s-1, 
range: 334 – 950) (P < 0.0001, n = 12, Wilcoxon signed rank test; Fig. 3C). 
The L-type Ca2+ channel antagonist nifedipine (1 μM) abolished sAPs (Fig. 4A), 
and thus removed all depolarizations >40 mV (Fig. 4B). We wanted to test the 
hypothesis that a sub-population of large-amplitude depolarizations may trigger sAPs. 
If so, nifedipine should reveal a sub-population of large-amplitude sDeps. No such sub-
population of large amplitude (e.g. 30 – 40 mV) sDeps was observed (e.g. data from a 
single, long-duration recording. Control, median amplitude: 8.8 mV, interquartile range: 
6 – 13 mV, post-nifedipine: 8.1 mV, 6 – 14 mV; no. of sDeps was 996 and 355 for the 
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control and post-nifedipine periods, respectively. P = NS, Mann-Whitney U test) (Fig. 
4B). 
However, the peak inward current through P2X1 receptors might provide a more 
sensitive measure of transmitter release than the amplitude of sDeps. To assess the 
inward current through P2X1 receptors, the differentiated rising phases of only sDeps, 
pre- and post-superfusion with nifedipine (1 μM), were compared. The amplitude of the 
first derivative of the sDep increased from 237 mV.s-1 in control cells (median 
amplitude; range: 182 – 359) to 268 mV.s-1 (range: 196 – 422) following nifedipine 
superfusion (i.e. to 113 ± 3% of controls; Student’s one-tailed paired t-test, P < 0.05, n 
= 4) (data shown for one experiment, Fig. 4C). In control cells of these experiments, 
sAPs represented 12% (range: 3 – 21) of all depolarizations. 
 
The relationship between spontaneous depolarizations and focal Ca2+ transients 
Loading detrusor smooth muscle with the Ca2+ indicator Oregon Green BAPTA-1 AM 
revealed three types of spontaneous Ca2+ transient (whole cell Ca2+ flashes, Ca2+ 
waves and focal Ca2+ transients), as reported by Meng et al. (2008). Simultaneous 
electrophysiology and confocal imaging of Ca2+ indicator fluorescence was used to 
determine the relationship between spontaneous depolarizations (sDeps) of the 
membrane potential of SMCs, with spontaneous focal, transient increases in 
fluorescence. Focal Ca2+ transients (Fig. 5A) were coincident with sDeps (Figs 5B,C). 
The relationship between these two events was explored with higher temporal 
resolution (2 kHz), by correlating line-scans taken along the long axis of a SMC (Fig. 
6A), with a simultaneous measure of the membrane potential, recorded with an 
intracellular electrode impaled in the imaged cell. A focal Ca2+ transient occurred as a 
local event along the x-axis of the line-scan (Fig. 6B). A measure of the intensity of the 
Ca2+ fluorescence for this region revealed a rapid rise in [Ca2+] over a period of 
approximately 100 ms, and then a slow decline to baseline (Fig. 6C). For the same 
period of time and in the same cell, a sDep was observed that exhibits a rise-to-peak 
amplitude and time course of decay that was much more rapid than the concurrent 
focal Ca2+ transient (459 ms; median half decay time: 568 ms, range 329 – 921; n = 3). 
Expanding the scale (Fig. 6D), the rise in [Ca2+] starts approximately 8 ms after the 
initiation of the sDep. The latency of rise in [Ca2+] relative to the initiation of a sDep was 
calculated for 12 events occurring in preparations from 3 animals. The median latency 
was 10.4 ms (range: 4.3 – 25.8 ms). 
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The model fit to the Ca2+ signal (e.g. Fig. 6D) is based on an exponentially 
declining calcium influx, which is then removed by a first order process. The change in 
membrane potential is proportional to the number of P2X receptors open (i.e. the 
conductance change) and hence to the rate of Ca2+ influx (see Appendix). The sEJP 
fall time (median: 40 ms, interquartile range: 30 ms – 44 ms, calculated for 12 events 
which occurred in preparations from 3 animals) was similar to the estimate of the rate 
of Ca2+ influx, 1/k2 (median: 42 ms, 30 – 75 ms). There was no significant difference in 
the median time course of the sEJP and the modelled Ca2+ influx (1/k2) (P = NS, Mann-
Whitney U test), although these two measures were not correlated on a pair-wise basis 
(Spearman rank correlation, ρ = -0.23, and P = NS). 
In addition to the temporal correlation, there was also a correlation in the 
amplitudes of focal Ca2+ transients and sDeps, both for large and small amplitude 
events (Pearson product moment correlation, ρ > 0.41 and P < 0.05 for each of n = 3 
experiments; Fig. 7). 
Whole cell Ca2+ flashes and Ca2+ waves were also observed during 
simultaneous recordings, but both events occurred infrequently. Whole cell Ca2+ 
flashes were observed to be concurrent with sAPs but Ca2+ waves did not correlate 
with any changes of the membrane potential of the impaled SMC. 
In order to establish whether focal Ca2+ transients were associated with nerve 
terminal varicosities, parasympathetic neurones were visualized using the fluorescent 
dye, 3-3 Diethyloxardicarbocyanine iodide (DiOC2(5); Yoshikami & Okun, 
1984). Focal Ca2+ transients were observed close to nerve terminal varicosities (e.g. 
Supplementary Movie). 
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DISCUSSION 
Purinergic neurotransmission in the detrusor muscle of the human urinary bladder is 
up-regulated in pathological states (Palea et al. 1993) and with ageing (Yoshida et al. 
2001). The mouse is an ideal model for the study of purinergic neurotransmission due 
to the relative ease with which transgenic animals can be produced (e.g. Vial & Evans, 
2000) and because purinergic neurotransmission is a major component of detrusor 
excitation in this species (Holt et al. 1985; Meng et al. 2008). Thus, the aim of the 
current study was to characterise further spontaneous purinergic neurotransmission in 
the mouse urinary bladder, by first determining the origin of frequent ‘spontaneous 
depolarizations’ and spontaneous action potentials in smooth muscle cells (SMCs), 
and second to investigate their relationship to ‘purinergic Ca2+ transients’ (Heppner et 
al. 2005) identified in rat urinary bladder smooth muscle cells. 
 
Spontaneous depolarizations are neurogenic, purinergic spontaneous excitatory 
junction potentials 
ATP, released from nerve terminals, acts on P2X1 receptors to cause frequent 
spontaneous depolarizations (sDeps) in the mouse urinary bladder. First, sDeps 
recorded using intracellular electrophysiology from SMCs were demonstrated to be 
purinergic in origin, consistent with the study of Meng et al. (2008). In the present 
study, sDeps were shown to be the result of ATP binding to P2X1 receptors, as they 
were almost abolished by the specific P2X1 receptor antagonist NF449 and the 
desensitising agonist α,β-mATP (Fig. 1B). This conclusion is supported by the study of 
Vial and Evans (2000), in which ATP-induced inward currents were not present in 
bladder SMCs isolated from P2X1 receptor deficient mice. Also consistent with Meng et 
al. (2008) was the insensitivity of sDeps to atropine (1 μM; Fig. 1B). Second, the ATP 
that causes sDeps was shown to be released from nerve terminals. Following 
superfusion of α-latrotoxin (LTX; 1 nM), an agent which stimulates spontaneous 
neurotransmitter release (Ceccarelli & Hurlbut, 1980), the frequency of sDeps 
increased markedly (Fig. 2A). LTX-stimulated sDeps were abolished by NF449 (Fig. 
2C) but were insensitive to atropine (Fig. 2B), suggesting that LTX did not stimulate 
acetylcholine release that, in turn, stimulated ATP release from, for example, SMCs. 
The possibility that sDeps could be generated by spontaneous transient inward 
currents (‘STICs’) seems unlikely given that the time-course of sDeps (49 ± 26 ms; 
Meng et al. 2008), is an order of magnitude briefer than stretch-induced STICs in 
isolated SMCs (approx. 500 ms; Ji et al. 2002). The detection of the sDeps before the 
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onset of local Ca2+ transients (by about 10 ms), also argues against the Ca2+ transient 
activating a local ion conductance to generate a depolarization. 
It should also be noted that there is unlikely to be any influence from 
urothelium-derived ATP (produced, for example, in response to stretch; Burnstock, 
2001) as experiments were performed on muscle strips following careful removal of the 
urothelium, and recordings were made from the serosal surface. 
The observations that sDeps were (i) increased in frequency by LTX, (ii) 
unaffected by TTX and (iii) that their time course is very different to that of STICs 
recorded from isolated myocytes, imply that sDeps are the result of spontaneous 
neurotransmitter release from nerve terminals and are, therefore, spontaneous 
excitatory junction potentials (sEJPs). 
 
Spontaneous action potentials (sAPs) are neurogenic and purinergic  
Spontaneous action potentials (sAPs) were demonstrated to have a similar origin to 
sEJPs, i.e. nerve terminal-released ATP. sAPs, present in 38% of control cells 
sampled, were not observed in any cells following the superfusion of NF449 and were 
almost abolished following P2X1 receptor desensitization with α,β-mATP. By contrast, 
atropine (1 μM) did not affect the frequency of sAPs. These findings suggest that sAP 
frequency at rest is driven by the action of ATP on P2X1 receptors rather than by 
acetylcholine. 
sAP frequency was not influenced by spontaneous activation of nerve branches 
or spontaneous nerve terminal action potentials, as the frequency of sAPs was similar 
in control cells (0.52 min-1; observed in 6 of 28 SMCs) to those superfused with TTX for 
1 h (0.73 min-1; observed in 7 of 28 SMCs). In order to investigate whether sAPs result 
from nerve terminal-released ATP, experiments were performed in the presence of 
LTX. Superfusion of LTX (1 nM) for 10 mins increased sAP frequency to 930 ± 450% of 
control. 
During the present series of experiments, the sAPs had a broad range of rise 
times with a prominent after-hyperpolarization, similar to the pacemaker-type sAPs 
described previously (Meng et al. 2008). Very few action potentials with only an after-
depolarization (described previously as spike-type) were observed; such a difference 
might have arisen because the shallow angle of incidence of the electrode used in 
present work might select more superficial cells than the more vertical electrode 
approach used by Meng, Young and Brading (JSY – personal observation). The 
shallow angle of electrode approach is necessary for the simultaneous Ca2+ imaging 
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experiments, so simultaneous recordings of a significant number of spike-type sAPs 
with Ca2+ measurements presents an unconquered technical hurdle. 
 
The relationship between sEJPs and sAPs 
It is likely that the EJP is the basis of urinary bladder smooth muscle action potentials; 
weak electrical stimulation evokes only an EJP, while stronger stimulation evokes an 
action potential (e.g. Creed et al. 1983; Brading & Mostwin, 1989).  
Both sEJPs and sAPs occur with highly variable times-to-peak, ranging from 5 – 
89 ms for sEJPs and 11 – 49 ms for sAPs. The peak amplitude of the first time 
derivative of the rising phase is proportional to the peak current into the cell (Young et 
al. 2007b), thus in order to test the hypothesis that sAPs arise when the P2X1 receptor 
current is high, the rising phases of both sEJPs and sAPs were differentiated for 
comparison. For a sAP, the differentiated rising phase revealed two peaks; the first 
attributed to the influx of cations through the P2X receptor, and second, the influx of 
Ca2+ ions through VDCCs (Fig. 3B). Thus comparing only the first peak of the 
differentiated rising phase of the depolarization revealed that the amplitude of the first 
derivative was much greater for sAPs than sEJPs. To further assess whether VDCC 
opening is correlated with the peak current into the cell through P2X1 receptors, the 
differentiated rising phases of sEJPs were compared pre- and post-VDCC blockade. 
There was a significant increase in the amplitude of the first derivative following 
nifedipine (1 μM) superfusion. The magnitude of the increase in first derivative 
amplitudes following nifedipine superfusion was, however, relatively small (13 ± 3%), 
but this is consistent with sAPs representing only a small proportion (12%) of the 
depolarizations observed. 
An increase in the median first derivative amplitude following VDCC blockade, 
taken together with a greater amplitude of the first derivative for sAPs than sDeps, 
suggests that sAPs are generated when a large amplitude post-junctional response to 
spontaneous ATP release from nerve terminals depolarises the smooth muscle 
membrane potential to the voltage-threshold for L-type Ca2+ channels. 
 
Focal Ca2+ transients are concurrent with sEJPs in mouse urinary bladder SMCs 
Confocal imaging of Ca2+ fluorescence identified, for the first time, frequent, 
spontaneous focal Ca2+ transients in SMCs of the mouse urinary bladder (Fig. 5A). 
These events were similar in appearance and time-course to purinergic Ca2+ transients 
of SMCs of mouse vas deferens (Brain et al. 2002), rat mesenteric arteries (Lamont & 
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Wier, 2002) and the rat urinary bladder (referred to there as ‘localized Ca2+ transients’; 
Heppner et al. 2005). To determine the relationship between the focal Ca2+ transients 
of the mouse urinary bladder and sEJPs, simultaneous intracellular electrophysiology 
and confocal imaging of Ca2+ fluorescence were performed. A temporal correlation 
between focal Ca2+ transients and sEJPs (Figs 5B,C) was further examined at a high (2 
kHz) resolution, which revealed a 10.4 ± 3.3 ms delay between the onset of a focal 
Ca2+ transient and a sEJP recorded from the same SMC (Fig. 6D). This delay is of 
similar magnitude to the delay at neuroeffector junctions of the mouse vas deferens (6 
ms; Brain et al. 2002) and rat urinary bladder (12 – 16 ms; Heppner et al. 2005). 
Binding of ATP to P2X1 receptors generates an influx of Na+ ions and Ca2+ ions 
(Isenberg et al. 1992; Evans et al. 1996), but it is unlikely that these movements are 
genuinely separated by 10 ms in SMCs of the mouse urinary bladder. During the first 
few milliseconds, the Ca2+ entering the cell is located close to the P2X receptors; the 
high local Ca2+ concentration saturates the high-affinity Ca2+ indicator so that the mean 
fluorescent signal under-estimates the mean Ca2+ concentration during the initial period 
of Ca2+ entry. This non-linearity might account for at least part of the estimated delay. 
High endogenous Ca2+ buffering close to the plasma membrane would also induce 
such an effect. It is also possible that CICR augments the Ca2+ that enters the cell 
through the P2X1 receptor upon ATP binding, causing the delay between the onsets of 
the sEJP and the focal Ca2+ transient. CICR has been demonstrated to contribute to 
purinergic Ca2+ transients in SMCs of the guinea-pig urinary bladder (Imaizumi et al. 
1998; Hashitani et al. 2000) and mouse vas deferens (Brain et al. 2003), but plays little 
role in SMCs of the mesenteric arteries (Lamont & Wier, 2002) or urinary bladder 
(Heppner et al. 2005) of rat. The potential contribution by CICR to focal Ca2+ transients 
in mouse urinary bladder SMCs awaits further experiments to inhibit CICR. 
 
Focal Ca2+ transients correlate in amplitude with concurrent sEJPs 
In addition to temporal coupling, focal Ca2+ transients and sEJPs were also correlated 
in amplitude throughout the amplitude range (Fig. 7). It has been suggested that 
spontaneous focal transients only arise from the release of the contents of a sub-
population of synaptic vesicles, giant dense cored vesicles (Blair et al. 2003), rather 
than all vesicle types. The correlation of focal Ca2+ transients with even low-amplitude 
sEJPs, also observed in another smooth muscle organ, the mouse vas deferens 
(Young et al. 2007a), argues against this hypothesis. As argued elsewhere (Young et 
al. 2007a), an amplitude correlation of focal Ca2+ transients and sEJPs is contrary to 
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the hypothesis that the variable amplitude of sEJPs results from the attenuation of 
depolarizations originating from distant release sites on neighbouring SMCs (Tomita, 
1970; Purves, 1976). The hypothesis that the variable sEJP amplitudes represent the 
effects of ATP on only the impaled cell (Young et al. 2007a) is supported by the high 
input resistances of SMCs (388 ± 83 MΩ) in this tissue (Meng et al. 2008). 
The observation that sEJP fall time (40 ms) was similar to the estimate of the 
rate of Ca2+ influx, 1/k2 (42 ms) argues that the focal Ca2+ transients and sEJPs within a 
SMC are determined by a common mechanism - ion conductance through P2X1 
receptors. 
As the focal Ca2+ transients described in the present study were shown to be 
correlated in timing and amplitude with sEJPs, themselves abolished by the P2X1 
receptor antagonist NF449, it is likely that the focal Ca2+ transients are purinergic in 
origin. It is unlikely that the focal Ca2+ transients observed are sparks, as their time-
course (half decay time, 568 ms) was similar to purinergic Ca2+ transients of rat urinary 
bladder smooth muscle (112 ± 9 ms; Heppner et al. 2005) and much greater than that 
of sparks in urinary bladder smooth muscle (34 ± 5 ms, Heppner et al. 2005), mouse 
urinary bladder myocytes (69 ± 9 ms, Fritz et al. 2007) or vascular smooth muscle 
(range from 27 ms, Mironneau et al. 1996; to 61 ms, Jaggar et al. 1998). 
 
Whole cell Ca2+ flashes correlate with sAPs 
The present work confirms a correlation between whole cell Ca2+ flashes and sAPs. 
The whole cell Ca2+ flashes seem to represent the same type of event described as 
‘global Ca2+ flashes’ in rat urinary bladder smooth muscle cells (Heppner et al. 2005), 
as they have similar spatial and temporal characteristic, are abolished when L-type 
Ca2+ channels are blocked, and decreased in frequency by P2X receptor inhibition or 
desensitization. In both cases these Ca2+ transients arise as a consequence of smooth 
muscle action potentials, commonly initiated by the action of ATP on P2X receptors. 
 
 
Conclusions 
We have characterised spontaneous purinergic neurotransmission in mouse urinary 
bladder smooth muscle, demonstrating frequent sEJPs and sAPs that result from 
nerve-released ATP binding to P2X1 receptors; sAPs occurring when the P2X1 current 
is sufficient to trigger L-type Ca2+ channel opening. sEJPs correlate in timing and 
amplitude with focal Ca2+ transients, suggesting that both events result from the same 
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quanta of ATP binding to P2X1 receptors and providing further evidence for a variable 
effective postjunctional response to ATP binding in electrically well-coupled smooth 
muscle. The present study demonstrates that sAPs and sEJPs are triggered by the 
stochastic release of ATP from parasympathetic nerve terminals. 
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APPENDIX 
In SMCs of many organs the time course of the sEJP is determined by the rate at 
which P2X1 channels inactivate (Åstrand et al. 1988). To model the Ca2+ kinetics in a 
focal Ca2+ transient, consider the P2X1 receptors opening rapidly at t=0 and then 
closing stochastically with a time constant of k2. It is hypothesised that the P2X1 
receptor is the primary, or only, conductance for Ca2+ under these conditions. Hence, 
the Ca2+ influx also falls exponentially with a rate constant of k2. Assume that Ca2+ is 
removed from the cells by a first order process with a rate constant of k1, then the 
change in Ca2+ concentration (C) is given by: 
dC
dt
= Aoe
−k2t
− k1C    (1) 
This has the solution (given the limiting case of C=0 as t goes to infinity): 
C = Ao
k2 − k1( ) e
−k1t
− e−k2t( )  (2) 
This can be checked by substitution. 
Fitting this function to experimentally obtained line-scanning confocal microscopy data 
of smooth muscle Ca2+ during a focal Ca2+ transient allows k2 to be calculated and 
compared with the known sEJP time constant. 
The time at the peak Ca2+ concentration (tmax; found when dCdt = 0 ) is: 
tmax =
ln k1
k2
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
k1 − k2( ) 
The peak Ca2+ concentration (Cmax) is hence found (by substituting tmax into (2)) to be: 
Cmax =
Ao
k2 − k1( )
k1
k2
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
−k1
k1 −k2( )
−
k1
k2
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
−k2
k1 −k2( )
⎛ 
⎝ 
⎜ 
⎜ 
⎜ 
⎞ 
⎠ 
⎟ 
⎟ 
⎟ 
 
So, for constants k1 and k2, the peak Ca2+ concentration (Cmax) is proportional to the 
number of P2X1 receptors opened at t=0 (as this is proportional to Ao). 
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FIGURE LEGENDS 
Figure 1. Spontaneous depolarizations (sDeps) are purinergic in origin. A, 
Comparing the effects of the superfusion of the P2X1 antagonist NF449 (10 μM) (i), the 
P2X1 desensitizing agent α,β-methylene ATP (α,β-mATP; 1 μM) (ii), the muscarinic 
acetylcholine receptor antagonist atropine (1 μM) (iii), a blocker of Na+ channels, 
tetrodotoxin (TTX, 1 μM) (iv), and an antagonist of L-type Ca2+ channels, nifedipine 
(1 μM) (v) on the membrane potential of SMCs. Note the longer time-scale of Aii. A 
depolarization and increase in the sAP frequency induced by α,β-mATP (Aii) is initially 
noted (consistent with its action as an agonist), before the membrane potential returns 
towards its resting level and the sAPs decline in frequency (presumably as the 
receptors desensitize). B, A comparison of the frequency of sDeps for each drug 
application to normalized control frequencies, with paired t-test statistical comparisons 
(see text for details). 
 
Figure 2. Spontaneous depolarizations are neurogenic. A, α-latrotoxin (LTX; 1 nM), 
which serves to increase the rate of spontaneous neurotransmitter release, caused an 
increase in the frequency of sDeps and spontaneous action potentials (sAPs). B, 
Similarly, the superfusion of LTX and atropine (1 μM) produced a marked increase in 
the frequency of sDeps and sAPs. C, Superfusion of LTX in combination with NF449 
(10 μM), however, abolished all depolarizations. Data shown (i.e. control, then 
following 15 minutes drug superfusion) are excerpts from continuous recordings. 
 
Figure 3. Peaks in the differentiated rising phases of sAPs are of, on average, 
larger amplitude than the differentiated peaks of sDeps. A, sDeps (grey trace) 
occurred with variable rising phases. When differentiated (black trace), peaks (arrows) 
occurred with a positively-skewed amplitude distribution. B, sAPs (grey trace), which 
occurred with similarly varying waveforms as sDeps, reveal two peaks (arrows) when 
differentiated (black trace); the amplitude of the first peak of which has a broad 
amplitude distribution. Data shown for A and B are from a single, long-duration 
recording. Bin sizes for the amplitude distributions of first derivatives are 0.125 V.s-1. 
Note that the scale bars associated with the raw data of A and B are of differing 
magnitudes, and that the differentiated sAPs (B) are truncated at -1 V.s-1. C, The 
median amplitude of the first peak of the differentiated sAP is greater than the 
amplitude of the differentiated sDep. Data are median, quartiles and range (n = 12). 
See text for details of statistical comparison. 
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Figure 4. Blocking sAPs, through the application of nifedipine, reveals a sub-
population of sDeps with especially rapid rising phase. A, Superfusion of nifedipine 
(1 μM; 15 minutes superfusion) abolished sAPs in murine detrusor smooth muscle. A 
spontaneous depolarization with a following prolonged hyperpolarization was 
incidentally observed in the trace in the presence of nifedipine; such events were also 
occasionally observed in control cells (not shown) and have not been further 
characterized. Data shown are from a continuous recording. B, The amplitude 
frequency distribution post-nifedipine does not reveal a sub-population of large 
amplitude sDeps; only the loss of depolarizations >40 mV in amplitude. The threshold 
for detecting sEJPs was 2 mV. C, Differentiated rising phases of sDeps reveal an 
increase in the frequency of larger amplitude events following nifedipine (1 μM) 
superfusion, compared to a control period. 
 
Figure 5. Spontaneous focal Ca2+ transients are coincident with spontaneous 
depolarizations (sDeps) in mouse urinary bladder smooth muscle. A, A region of a 
smooth muscle cell (SMC) in a mouse isolated urinary bladder (loaded with the Ca2+ -
indicator Oregon Green 488 BAPTA-1 AM) during an intracellular recording. Images, 
acquired at 13.5 Hz, are 4 consecutive frames of a 200 frame series. A spontaneous 
focal Ca2+ transient occurred on frame ii (arrowhead). B, Intracellular recording of a 
period that includes the same four frames that compose (A), showing simultaneous 
recordings of membrane potential (black line) and whole cell fluorescence (grey dots). 
C, Simultaneous Ca2+ imaging and electrophysiology demonstrate the coincidence of 
focal Ca2+ transients and sDeps during a longer period. 
 
Figure 6. Simultaneous Ca2+ imaging and electrophysiological measurement at a 
higher temporal resolution of imaging reveal the temporal relationship between 
focal Ca2+ transients and sDeps. A, A region of a smooth muscle cell (SMC) in a 
mouse isolated urinary bladder (loaded with the Ca2+ indicator Oregon Green 488 
BAPTA-1 AM) during an intracellular recording. Line scans were taken along the long 
axis of an impaled SMC, the position of which is denoted by the dashed white line. B, 
Line scan, acquired at 2 kHz, of the SMC (A) showing the occurrence of a focal Ca2+ 
transient (arrow). C, A measure of the Ca2+ fluorescence for a 20 μm region of the 
SMC in which the focal Ca2+ transient occurs (grey) compared to the membrane 
potential of the same cell for the same period of time (black). D, The occurrence of the 
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focal Ca2+ transient (grey) and sDep (black) shown on an expanded time scale. The 
dark grey line of Ca2+ fluorescence (C,D) is a curve fitted using a custom-written script; 
see Methods for details. 
 
Figure 7. Focal Ca2+ transients and concurrent spontaneous depolarizations are 
correlated in amplitude. Correlations are shown for three recordings in which there 
were sufficient events to draw comparison of amplitudes. 
Focal Ca2+ transient amplitude = ΔF .area
Fo
 
Where ΔF is the change in fluorescence, Fo the resting fluorescence and area is the 
area over which the fluorescent signal is measured (in pixels) divided by 32; this is 
hence an arbitrary unit. 
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